KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 112 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,545,886 | +40.4% | 146,568 | +13.8% | 0.00% | – |
| Q2 2023 | $1,813,195 | +31.7% | 128,778 | +0.6% | 0.00% | – |
| Q1 2023 | $1,376,743 | -27.8% | 127,950 | +0.5% | 0.00% | – |
| Q4 2022 | $1,907,658 | +18.3% | 127,347 | +1.4% | 0.00% | – |
| Q3 2022 | $1,612,000 | +37.8% | 125,528 | +4.1% | 0.00% | – |
| Q2 2022 | $1,170,000 | -14.2% | 120,637 | -11.9% | 0.00% | – |
| Q1 2022 | $1,363,000 | -13.5% | 137,001 | +2.3% | 0.00% | – |
| Q4 2021 | $1,576,000 | +2.5% | 133,906 | -0.8% | 0.00% | – |
| Q3 2021 | $1,537,000 | -16.1% | 134,997 | +2.8% | 0.00% | – |
| Q2 2021 | $1,831,000 | -26.4% | 131,359 | -2.3% | 0.00% | -100.0% |
| Q1 2021 | $2,489,000 | +2.9% | 134,415 | -1.8% | 0.00% | 0.0% |
| Q4 2020 | $2,418,000 | +73.6% | 136,863 | +50.5% | 0.00% | – |
| Q3 2020 | $1,393,000 | -29.5% | 90,954 | +17.3% | 0.00% | -100.0% |
| Q2 2020 | $1,975,000 | +164.4% | 77,517 | +60.8% | 0.00% | – |
| Q1 2020 | $747,000 | +45.9% | 48,222 | +4.3% | 0.00% | – |
| Q4 2019 | $512,000 | +15.1% | 46,224 | -11.5% | 0.00% | – |
| Q3 2019 | $445,000 | -41.8% | 52,213 | -7.4% | 0.00% | – |
| Q2 2019 | $764,000 | -9.9% | 56,371 | +20.1% | 0.00% | – |
| Q1 2019 | $848,000 | +46.7% | 46,944 | +128.2% | 0.00% | – |
| Q4 2018 | $578,000 | +32.9% | 20,570 | +20.5% | 0.00% | – |
| Q3 2018 | $435,000 | – | 17,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |